| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.011 | 1 |